Therefore, the Zacks rating upgrade for Sensei Biotherapeutics basically reflects positivity about its earnings outlook that could translate into buying pressure and an increase in its stock price.

Adobe (NASDAQ: ADBE) shareholders might wish they could use Photoshop, the tech giant's flagship image-editing tool, to magically erase the stock's disappointing performance in 2024. Despite solid ...

04, 2025 (GLOBE NEWSWIRE) -- Sensei Biotherapeutics ... a As the major U.S. stock indexes hover near record levels, investors are keenly observing market movements and economic indicators for ...

Nevertheless, Adobe remains on a firm footing into 2025, supported by overall strong fundamentals and several factors positioning the stock to rebound. With shares trading near a 52-week low ...

Adobe, Inc. engages in the provision of digital marketing and media solutions. It operates through the following segments: Digital Media, Digital Experience, and Publishing and Advertising. The ...